Sensex, Nifty, Midcap under pressure; Metals shine, Pharma down 1.5%

Sun Pharma to acquire Ranbaxy in $4 billion all-stock dealSun Pharma to acquire Ranbaxy in $4 billion all-stock deal

Equity benchmarks remained under pressure in afternoon, weighed by pharma stocks and Reliance Industries.

The 30-share BSE Sensex was down 88.94 points at 32,148.94 and the 50-share NSE Nifty fell 13.40 points to 10,000.25 amid consolidation.

About 1,338 shares declined against 941 advancing shares on the BSE.

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300